Lung microstructure in adolescent idiopathic scoliosis before and after posterior spinal fusion.
Lung microstructure in adolescent idiopathic scoliosis before and after posterior spinal fusion.
复制标题
DOI:
10.1371/journal.pone.0240265
复制
发表时间:
2020
期刊:
影响因子:
3.7
通讯作者:
Varisco BM
中科院分区:
文献类型:
--
作者:
Thomen RP;Woods JC;Sturm PF;Jain V;Walkup LL;Higano NS;Quirk JD;Varisco BM
Adolescent idiopathic scoliosis (AIS) is associated with decreased respiratory quality of life and impaired diaphragm function. Recent hyperpolarized helium (HHe) MRI studies show alveolarization continues throughout adolescence, and mechanical forces are known to impact alveolarization. We therefore hypothesized that patients with AIS would have alterations in alveolar size, alveolar number, or alveolar septal dimensions compared to adolescents without AIS, and that posterior spinal fusion (PSF) might reverse these differences. We conducted a prospective observational trial using HHe MRI to test for changes in alveolar microstructure in control and AIS subjects at baseline and one year. After obtaining written informed consent from subjects’ legal guardians and assent from the subjects, we performed HHe and proton MRI in 14 AIS and 16 control subjects aged 8–21 years. The mean age of control subjects (12.9 years) was significantly less than AIS (14.9 years, p = 0.003). At baseline, there were no significant differences in alveolar size, number, or alveolar duct morphometry between AIS and control subjects or between the concave (compressed) and convex (expanded) lungs of AIS subjects. At one year after PSF AIS subjects had an increase in alveolar density in the formerly convex lung (p = 0.05), likely reflecting a change in thoracic anatomy, but there were no other significant changes in lung microstructure. Modeling of alveolar size over time demonstrated similar rates of alveolar growth in control and AIS subjects in both right and left lungs pre- and post-PSF. Although this study suffered from poor age-matching, we found no evidence that AIS or PSF impacts lung microstructure. Trial registration: Clinical trial registration number NCT03539770.
登录
查看更多内容
影响因子:
2.2
作者:
Sukstanskii, A. L.;Yablonskiy, D. A.
通讯作者:
Yablonskiy, D. A.
影响因子:
3.3
作者:
Flors, Lucia;Mugler, John P., III;Altes, Talissa A.
通讯作者:
Altes, Talissa A.
DOI:
10.1164/rccm.201107-1348oc
发表时间:
2012-01-15
影响因子:
24.7
作者:
Narayanan, Manjith;Owers-Bradley, John;Silverman, Michael
通讯作者:
Silverman, Michael
DOI:
10.1164/rccm.201802-0274oc
发表时间:
2018-12-15
影响因子:
24.7
作者:
Mahmoud, Osama;Granell, Raquel;Henderson, John
通讯作者:
Henderson, John
影响因子:
3
作者:
Bunn, Andrew G.
通讯作者:
Bunn, Andrew G.